FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2463322501> ?p ?o ?g. }

• W2463322501 abstract "Abstract Abstract 1728 The target antigen CAMPATH-1 (CD52) is widely expressed in various hematopoietic lineages inlcuding lymphocytes, basophils, and blood monocytes. The anti-CD52 antibody Alemtuzumab is used successfully to treat patients with chemotherapy-refractory chronic lymphocytic leukemia. Based on its strong immunosuppressive effects, Alemtuzumab has also been considered for patients with aplastic anemia and hypoplastic myelodysplastic syndromes (MDS). Indeed, more recently, Alemtuzumab was found to induce major hematologic responses in a group of patients with MDS. Although the immunosuppressive effect was considered to play a role, the exact mechanisms underlying this drug effect remained speculative. In the current study, we asked whether CD34+ bone marrow (BM) progenitor cells in MDS and acute myeloid leukemia (AML) express the CAMPATH-1 antigen. Twelve patients with MDS (5 females, 7 males; median age: 70 years), 25 patients with AML (16 females, 9 males; median age: 62 years), and 34 control cases (normal reactive BM, n=12; idiopathic cytopenia of unknown significance, n=11; chronic myeloid leukemia, CML, n=4; chronic myelomonocytic leukemia, CMML, n=3; JAK2 V617F+ myeloproliferative neoplasms, MPN, n=4) were examined. Surface expression of CD52 on CD34+/CD38+ and CD34+/CD38- BM progenitor cells was analyzed by monoclonal antibodies and multicolor flow cytometry. In the group of MDS, CD52 was detectable on CD34+/CD38- stem cells in 3/4 patients with isolated 5q-. In most of the other MDS patients, CD52 was weakly expressed or not detectable on CD34+/CD38- cells. In AML, CD34+/CD38- cells displayed CD52 in 12/25 patients, namely 3 with complex karyotype including 5q-, 2 with inv(3), one with t(8;21), one with inv(16), one with del13q, one with trisomy 8, one with monosomy 7, and 2 with normal karyotype. Expression of CD52 mRNA in CD34+/CD38- AML stem cells was confirmed by qPCR in all patients tested (n=14). In addition, a good correlation was found between surface CD52 expression and CD52 mRNA expression in AML progenitor fractions. In patients with normal hematopoiesis (n=12) or idiopathic cytopenia (n=11), CD34+/CD38- cells stained weakly positive or negative for CD52. Almost in all cases tested, blood monocytes and blood basophils stained positive for CD52. Together, our data suggest that the target antigen CAMPATH-1 (CD52) is expressed on primitive CD34+/CD38- progenitor cells in MDS, preferentially in 5q- patients, and in a subset of patients with AML. These observations may have clinical implications and explain recently described effects of Alemtuzumab in patients with MDS. Our data also suggest that Alemtuzumab may be an interesting targeted drug in patients with refractory or relapsed AML in whom neoplastic stem cells express the target antigen CD52. Disclosures: No relevant conflicts of interest to declare." @default.
• W2463322501 created "2016-07-22" @default.
• W2463322501 creator A5006306448 @default.
• W2463322501 creator A5036547515 @default.
• W2463322501 creator A5052025914 @default.
• W2463322501 creator A5057442322 @default.
• W2463322501 creator A5072949561 @default.
• W2463322501 creator A5083642522 @default.
• W2463322501 date "2011-11-18" @default.
• W2463322501 modified "2023-09-27" @default.
• W2463322501 title "Expression of the CAMPATH-1 Antigen (CD52) on CD34+/CD38- Progenitor Cells in Patients with 5q- MDS and in a Subset of AML" @default.
• W2463322501 doi "https://doi.org/10.1182/blood.v118.21.1728.1728" @default.
• W2463322501 hasPublicationYear "2011" @default.
• W2463322501 type Work @default.
• W2463322501 sameAs 2463322501 @default.
• W2463322501 citedByCount "0" @default.
• W2463322501 crossrefType "journal-article" @default.
• W2463322501 hasAuthorship W2463322501A5006306448 @default.
• W2463322501 hasAuthorship W2463322501A5036547515 @default.
• W2463322501 hasAuthorship W2463322501A5052025914 @default.
• W2463322501 hasAuthorship W2463322501A5057442322 @default.
• W2463322501 hasAuthorship W2463322501A5072949561 @default.
• W2463322501 hasAuthorship W2463322501A5083642522 @default.
• W2463322501 hasConcept C10205521 @default.
• W2463322501 hasConcept C109159458 @default.
• W2463322501 hasConcept C126322002 @default.
• W2463322501 hasConcept C147483822 @default.
• W2463322501 hasConcept C159654299 @default.
• W2463322501 hasConcept C203014093 @default.
• W2463322501 hasConcept C2777938653 @default.
• W2463322501 hasConcept C2778384904 @default.
• W2463322501 hasConcept C2778461978 @default.
• W2463322501 hasConcept C2778729363 @default.
• W2463322501 hasConcept C2779015954 @default.
• W2463322501 hasConcept C2779282312 @default.
• W2463322501 hasConcept C2780007613 @default.
• W2463322501 hasConcept C2780366003 @default.
• W2463322501 hasConcept C2780817109 @default.
• W2463322501 hasConcept C2781440808 @default.
• W2463322501 hasConcept C28328180 @default.
• W2463322501 hasConcept C54355233 @default.
• W2463322501 hasConcept C71924100 @default.
• W2463322501 hasConcept C86803240 @default.
• W2463322501 hasConceptScore W2463322501C10205521 @default.
• W2463322501 hasConceptScore W2463322501C109159458 @default.
• W2463322501 hasConceptScore W2463322501C126322002 @default.
• W2463322501 hasConceptScore W2463322501C147483822 @default.
• W2463322501 hasConceptScore W2463322501C159654299 @default.
• W2463322501 hasConceptScore W2463322501C203014093 @default.
• W2463322501 hasConceptScore W2463322501C2777938653 @default.
• W2463322501 hasConceptScore W2463322501C2778384904 @default.
• W2463322501 hasConceptScore W2463322501C2778461978 @default.
• W2463322501 hasConceptScore W2463322501C2778729363 @default.
• W2463322501 hasConceptScore W2463322501C2779015954 @default.
• W2463322501 hasConceptScore W2463322501C2779282312 @default.
• W2463322501 hasConceptScore W2463322501C2780007613 @default.
• W2463322501 hasConceptScore W2463322501C2780366003 @default.
• W2463322501 hasConceptScore W2463322501C2780817109 @default.
• W2463322501 hasConceptScore W2463322501C2781440808 @default.
• W2463322501 hasConceptScore W2463322501C28328180 @default.
• W2463322501 hasConceptScore W2463322501C54355233 @default.
• W2463322501 hasConceptScore W2463322501C71924100 @default.
• W2463322501 hasConceptScore W2463322501C86803240 @default.
• W2463322501 hasLocation W24633225011 @default.
• W2463322501 hasOpenAccess W2463322501 @default.
• W2463322501 hasPrimaryLocation W24633225011 @default.
• W2463322501 hasRelatedWork W115546130 @default.
• W2463322501 hasRelatedWork W176161498 @default.
• W2463322501 hasRelatedWork W1964876958 @default.
• W2463322501 hasRelatedWork W2027442877 @default.
• W2463322501 hasRelatedWork W2084565115 @default.
• W2463322501 hasRelatedWork W2111020946 @default.
• W2463322501 hasRelatedWork W2163011273 @default.
• W2463322501 hasRelatedWork W2346342002 @default.
• W2463322501 hasRelatedWork W2355878366 @default.
• W2463322501 hasRelatedWork W2362036578 @default.
• W2463322501 hasRelatedWork W2364924448 @default.
• W2463322501 hasRelatedWork W2372947697 @default.
• W2463322501 hasRelatedWork W2377657824 @default.
• W2463322501 hasRelatedWork W2383236559 @default.
• W2463322501 hasRelatedWork W2549804860 @default.
• W2463322501 hasRelatedWork W2621284904 @default.
• W2463322501 hasRelatedWork W2991589465 @default.
• W2463322501 hasRelatedWork W3141972135 @default.
• W2463322501 hasRelatedWork W3144956108 @default.
• W2463322501 hasRelatedWork W34660950 @default.
• W2463322501 isParatext "false" @default.
• W2463322501 isRetracted "false" @default.
• W2463322501 magId "2463322501" @default.
• W2463322501 workType "article" @default.